TetraLogic Pharmaceuticals Corp
OTC:TLOG
TetraLogic Pharmaceuticals Corp
OTC:TLOG
Price:
0.0001
USD
Market Closed
Market Cap:
$2.5k
Cash Flow Statement
Cash Flow Statement
TetraLogic Pharmaceuticals Corp
TetraLogic Pharmaceuticals Corp
Currency: USD
| Mar-2013 | Jun-2013 | Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||
| Net Income |
(20)
|
(15)
|
(17)
|
(20)
|
(22)
|
(27)
|
(31)
|
(36)
|
(43)
|
(46)
|
(47)
|
(50)
|
(48)
|
(43)
|
(41)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Deffered Taxes |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
4
|
1
|
2
|
1
|
3
|
3
|
3
|
5
|
3
|
3
|
2
|
2
|
|
| Other Non-Cash Items |
1
|
1
|
3
|
6
|
6
|
7
|
6
|
6
|
9
|
8
|
11
|
13
|
13
|
13
|
18
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
4
|
4
|
4
|
4
|
4
|
4
|
|
| Change in Working Capital |
(1)
|
(0)
|
1
|
1
|
1
|
0
|
0
|
(3)
|
1
|
0
|
(0)
|
2
|
2
|
1
|
1
|
|
| Cash from Operating Activities |
(20)
N/A
|
(14)
+30%
|
(14)
+1%
|
(13)
+5%
|
(15)
-18%
|
(19)
-29%
|
(24)
-22%
|
(32)
-36%
|
(34)
-4%
|
(37)
-11%
|
(37)
+0%
|
(35)
+6%
|
(34)
+3%
|
(29)
+15%
|
(24)
+17%
|
|
| Investing Cash Flow | ||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
0
|
(28)
|
(46)
|
(61)
|
(53)
|
(13)
|
10
|
34
|
36
|
29
|
23
|
14
|
|
| Cash from Investing Activities |
5
N/A
|
(0)
N/A
|
(0)
N/A
|
(0)
-124%
|
(29)
-42 307%
|
(46)
-61%
|
(61)
-33%
|
(54)
+12%
|
(14)
+75%
|
10
N/A
|
34
+235%
|
35
+3%
|
29
-19%
|
22
-22%
|
14
-39%
|
|
| Financing Cash Flow | ||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
49
|
49
|
49
|
49
|
0
|
0
|
0
|
3
|
3
|
3
|
3
|
0
|
|
| Net Issuance of Debt |
5
|
13
|
13
|
14
|
14
|
50
|
50
|
44
|
43
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
5
N/A
|
13
+164%
|
13
N/A
|
63
+387%
|
64
+0%
|
100
+57%
|
100
N/A
|
44
-56%
|
43
-2%
|
(1)
N/A
|
2
N/A
|
2
-2%
|
3
+45%
|
3
N/A
|
0
N/A
|
|
| Change in Cash | ||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Net Change in Cash |
(9)
N/A
|
(1)
+93%
|
(0)
+29%
|
51
N/A
|
20
-61%
|
34
+72%
|
15
-57%
|
(42)
N/A
|
(4)
+91%
|
(28)
-638%
|
(1)
+96%
|
2
N/A
|
(2)
N/A
|
(4)
-55%
|
(10)
-167%
|
|
| Free Cash Flow | ||||||||||||||||
| Free Cash Flow |
(20)
N/A
|
(14)
+30%
|
(14)
+1%
|
(13)
+5%
|
(15)
-21%
|
(20)
-28%
|
(24)
-22%
|
(33)
-36%
|
(34)
-3%
|
(37)
-11%
|
(37)
+0%
|
(35)
+6%
|
(34)
+4%
|
(29)
+15%
|
(24)
+17%
|
|
Switch to:
Switch to:
See Also
Discover More
